1Yang WY, Lu JM, Weng JP, et al. Prevalence of diabetes amongmen and women in China[J]. N Engl J Med, 2010, 362(12):1090-1101.
2Muller M, Trocme C, Lardy B, et al. Matrix metalloproteinasesand diabetic foot ulcers: the ratio of MMP-1 to TIMP-1 is apredictor of wound healing[J]. Diabet Med, 2008, 25(4): 419-426.
6Rooke TW, Hirsch AT, Misra S, et al. 2011 ACCF/AHAFocused Update of the guideline for the management ofpatients with peripheral artery disease(Updating the 2005Guideline): A Report of the American College of Cardiology Foundation/American Heart Association Task Force on PracticeGuidelines[J]. Circulation, 2011, 124(18): 2020-2045.
7Hirsch AT, Haskal ZJ, Hertzer NR, et al. ACC/AHA 2005Practice Guidelines for the management of patients withperipheral arterial disease (lower extremity, renal, mesenteric,and abdominal aor tic): a col laborative repor t f rom theAmer ican Association for Vascular Surger y/Societ y forVascular Surgery, Society for Cardiovascular Angiographyand Interventions, Society for Vascular Medicine and Biology,Society of Interventional Radiology, and the ACC/AHA TaskForce on Practice Guidelines (Writing Committee to DevelopGuidelines for the Management of Patients With PeripheralArterial Disease): endorsed by the American Association ofCardiovascular and Pulmonary Rehabilitation; National Heart,Lung , and Blood Institute; Society for Vascular Nursing;TransAtlantic Inter-Society Consensus; and Vascular DiseaseFoundation[J]. Circulation, 2006, 113(11): e463-e654.
9Ji L, Hu D, Pan C, et al. Primacy of the 3B approach to controlrisk factors for cardiovascular disease in type 2 diabetespatients[J]. Am J Med, 2013, 126(10): 925. e11-e22.
10Liu J, Zhao D, Liu J, et al. Prevalence of diabetes mellitus inoutpatients with essential hypertension in China: a crosssectionalstudy[J]. BMJ Open, 2013, 3(11): e003798.
7Dickinson S,Brand-Miller J. Glycemic index, postprandial glycemia and cardiovascular disease[J]. Curt Opin Lipidol, 2005, 16(1):69-75.
8Choe C,Edelman SV. The role of self-monitoring of blood glucose during the treatment of type 2 diabetes with medications targeting postprandial hyperglycemia [J].South Med J,2007,100 (11): 1123- 1131.
9Turner RC,Millns H,Neil HA,et al. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus:United Kingdom Prospective Diabetes Study (UKPDS: 23)[J].BMJ,1998,316(7134): 823-828.
10Leiter LA,Ceriello A, Davidson JA,et al. Postprandial glucose regulation: new data and new implications [J]. Clin Ther,2005,27(Suppl B): S42-56.
8Kahn SE, Haffner SM, Heise MA, et al. Glycemic durability of rosiglitazone,metformin,or glyburide monotherapy[J]. N Engl J Med, 2006, 355(23):2427-2443.
9Kela R, Davies MJ. Treatment evaluation of liraglutide in type 2 diabetes[J]. Expert Opin Biol Ther, 2012, 12(I 1):1551.
10Varanasi A, Patel P, Makdissi A, et aL Clinical use of lira- glutide in type 2 diabetes and its effects on cardiovascular risk factors[J]. Endocr Pratt, 2012, 18(2):140. .
